Zealand Pharma A/S
Zealand Pharma A/S's email is info@zealandpharma.com
and
Zealand Pharma A/S's phone number is 45 88 77 36 00
.
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim. Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analogue for the treatment of Type 2 diabetes, is marketed globally outside the US as Lyxumia:registered: by Sanofi and under regulat...
read more
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) (“Zealand”) is a biotech company with leading-edge scientific expertise in turning peptides into medicines. Zealand has a growing proprietary pipeline of novel specialty drug candidates and a mature portfolio of products and projects under license collaborations with Sanofi, Helsinn Healthcare and Boehringer Ingelheim. Zealand’s first invented medicine, lixisenatide, a once-daily prandial GLP-1 analogue for the treatment of Type 2 diabetes, is marketed globally outside the US as Lyxumia:registered: by Sanofi and under regulatory review in the US. The license collaboration with Sanofi covers also a single-product combination of lixisenatide and insulin glargine (Lantus:registered:) which is on track for regulatory submission in the US in December 2015 and in the European Union in Q1 2016. The proprietary pipeline includes; danegaptide for ischemic reperfusion Injuries in Phase II development; ZP1848 for Short Bowel Syndrome in Phase II development; and the stable glucagon analogue, ZP4207, in Phase II preparation both as a single-dose rescue pen for severe hypoglycemia and for multiple-dose use to treat and control mild to moderate hypoglycemia; as well as several preclinical peptide therapeutics. The company is based in Copenhagen (Glostrup), Denmark. For further information about Zealand’s business and activities, please visit: www.zealandpharma.com or follow us on Twitter @ZealandPharma
show less
Website | zealandpharma.com | |
Industry | Biotechnology | |
Location | Copenhagen, Capital Region, Denmark | |
Employees | 342 | |
Founded | 1998 |
HQ | Smedeland 36 | |
Phone | 45 88 77 36 00 | |
info@zealandpharma.com | ||
Funding | 271,524,705 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | zealandpharma.com | |
Industry | Biotechnology | |
Location | Copenhagen, Capital Region, Denmark | |
Employees | 342 | |
Founded | 1998 | |
linkedin.com/company/zealand-pharma | ||
HQ | Smedeland 36 | |
Phone | 45 88 77 36 00 | |
info@zealandpharma.com | ||
Funding | 271,524,705 USD |
Email Patterns for Zealand Pharma A/S
Top Competitors for Zealand Pharma A/S
Zealand Pharma A/S Questions
Where are Zealand Pharma A/S's headquarters?
Zealand Pharma A/S's headquarters are in Smedeland 36
What is Zealand Pharma A/S's phone number?
Zealand Pharma A/S's phone number is 45 88 77 36 00
What is Zealand Pharma A/S's official website?
Zealand Pharma A/S's website is zealandpharma.com
How many employees are working in Zealand Pharma A/S right now?
Zealand Pharma A/S has
342 employees.
View the Email and Phone Numbers for all 342 working at Zealand Pharma A/S.
What is Zealand Pharma A/S's industry?
Zealand Pharma A/S's industry is
Biotechnology
Who are Zealand Pharma A/S's top competitors?
Zealand Pharma A/S's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Zealand Pharma A/S's email address?
Zealand Pharma A/S's email address is info@zealandpharma.com
What are Zealand Pharma A/S's categories?
Zealand Pharma A/S's categories are Biopharma, Biotechnology, Health Care
What is Zealand Pharma A/S's location?
Zealand Pharma A/S's location is
Copenhagen, Capital Region, Denmark
When was Zealand Pharma A/S's founded?
Zealand Pharma A/S's founding year is 1998
What is Zealand Pharma A/S's funding?
Zealand Pharma A/S's funding is 271,524,705 USD
What is Zealand Pharma A/S's current status?
Zealand Pharma A/S's current status is ipo
Top Zealand Pharma A/S Employees
Executive Territory Business Leader
melissaworkley@hotmail.com
+1214-727-0702
Senior Territory Business Leader
mclaire@valeritas.com
+1281-750-1875
Associate Director, Commercial Training And Operational Effectiveness
matt.mann@otsuka-us.com
+1609-759-5234
Director, Contract Strategy And Operations
palveald@yahoo.com
+1908-234-2796
Board Member
kd@symphogen.com
+1458-870-0325
Senior Vice President Clinical And Medical Affairs
michael.l.hall@comcast.net
+1617-817-6094
Territory Business Leader
paige.beachrdcde@yahoo.com
+1210-818-2590